ACS Chemical Biology
Articles
(7) Cashman, J. R., and Zhang, J. (2006) Human flavin-containing
mono-oxygenases. Annu. Rev. Pharmacol. Toxicol. 46, 65−100.
(8) Zhang, J., and Cashman, J. R. (2006) Quantitative analysis of
FMO gene mRNA levels in human tissues. Drug Metab. Dispos. 34,
19−26.
oxygenases: molecular characterization and regulation of expression.
Toxicol. Appl. Pharmacol. 125, 1−6.
(27) Lang, D. H., Yeung, C. K., Peter, R. M., Ibarra, C., Gasser, R.,
Itagaki, K., Philpot, R. M., and Rettie, A. E. (1998) Isoform specificity
of trimethylamine N-oxygenation by human flavin-containing mono-
oxygenase (FMO) and P450 enzymes: selective catalysis by FMO3.
Biochem. Pharmacol. 56, 1005−1012.
(28) Zhang, J., Cerny, M. A., Lawson, M., Mosadeghi, R., and
Cashman, J. R. (2007) Functional activity of the mouse flavin-
containing mono-oxygenase forms 1, 3, and 5. J. Biochem. Mol. Toxicol.
21, 206−215.
(29) Ohmi, N., Yoshida, H., Endo, H., Hasegawa, M., Akimoto, M.,
and Higuchi, S. (2003) S-oxidation of S-methyl-esonarimod by flavin-
containing mono-oxygenases in human liver microsomes. Xenobiotica
33, 1221−1231.
(9) Phillips, I. R., and Shephard, E. A. (2008) Flavin-containing
mono-oxygenases: mutations, disease and drug response. Trends
Pharmacol. Sci. 29, 294−301.
(10) Nagata, T., Williams, D. E., and Ziegler, D. M. (1990) Substrate
specificities of rabbit lung and porcine liver flavin-containing mono-
oxygenases: differences due to substrate size. Chem. Res. Toxicol. 3,
372−376.
(11) Overby, L. H., Buckpitt, A. R., Lawton, M. P., Atta-Asafo-Adjei,
E., Schulze, J., and Philpot, R. M. (1995) Characterization of flavin-
containing mono-oxygenase 5 (FMO5) cloned from human and
guinea pig: evidence that the unique catalytic properties of FMO5 are
not confined to the rabbit ortholog. Arch. Biochem. Biophys. 317, 275−
284.
(30) Leoni, C., Buratti, F. M., and Testai, E. (2008) The participation
of human hepatic P450 isoforms, flavin-containing mono-oxygenases
and aldehyde oxidase in the biotransformation of the insecticide
fenthion. Toxicol. Appl. Pharmacol. 233, 343−352.
(12) Hernandez, D., Janmohamed, A., Chandan, P., Phillips, I. R., and
Shephard, E. A. (2004) Organization and evolution of the flavin-
containing mono-oxygenase genes of human and mouse: identification
of novel gene and pseudogene clusters. Pharmacogenetics 14, 117−130.
(13) Riebel, A., de Gonzalo, G., and Fraaije, M. W. (2013) Expanding
the biocatalytic toolbox of flavoprotein mono-oxygenases from
Rhodococcus jostii RHA1. J. Mol. Catal. B: Enzym. 88, 20−25.
(14) Riebel, A., Fink, M. J., Mihovilovic, M. D., and Fraaije, M. W.
(2014) Type II flavin-containing mono-oxygenases: a new class of
biocatalysts that harbors Baeyer−Villiger mono-oxygenases with a
relaxed coenzyme specificity. ChemCatChem 6, 1112−17.
(15) Lai, W. G., Farah, N., Moniz, G. A., and Wong, Y. N. (2011) A
Baeyer-Villiger oxidation specifically catalyzed by human flavin-
containing mono-oxygenase 5. Drug. Metab. Dispos. 39, 61−70.
(16) Meng, J., Zhong, D., Li, L., Yuan, Z., Yuan, H., Xie, C., Zhou, J.,
Li, C., Gordeev, M. F., Liu, J., and Chen, X. (2015) Metabolism of
MRX-I, a novel antibacterial oxazolidinone, in humans: the oxidative
ring opening of 2,3-Dihydropyridin-4-one catalyzed by non-P450
enzymes. Drug Metab. Dispos. 43, 646−659.
(31) van Beek, H. L., Winter, R. T., Eastham, G. R., and Fraaije, M.
W. (2014) Synthesis of methyl propanoate by Baeyer-Villiger mono-
oxygenases. Chem. Commun. (Cambridge, U. K.) 50, 13034−13036.
(32) Leisch, H., Morley, K., and Lau, P. C. (2011) Baeyer-Villiger
mono-oxygenases: more than just green chemistry. Chem. Rev. 111,
4165−4222.
(33) Reignier, T., de Berardinis, V., Petit, J. L., Mariage, A., Hamze,
́
K., Duquesne, K., and Alphand, V. (2014) Broadening the scope of
Baeyer-Villiger mono-oxygenase activities toward α,β-unsaturated
ketones: a promising route to chiral enol-lactones and ene-lactones.
Chem. Commun. (Cambridge, U. K.) 50, 7793−7796.
(34) Branchaud, B. P., and Walsh, C. T. (1985) Functional group
diversity in enzymic oxygenation reactions catalyzed by bacterial flavin-
containing cyclohexanone oxygenase. J. Am. Chem. Soc. 107, 2153−
2157.
(35) Bisagni, S., Summers, B., Kara, S., Hatti-Kaul, R., Grogan, G.,
Mamo, G., and Hollmann, F. (2014) Exploring the substrate specificity
and enantioselectivity of a Baeyer−Villiger Monooxygenase from
Dietzia sp. D5: oxidation of sulfides and aldehydes. Top. Catal. 57,
366−375.
(17) Forneris, F., Orru, R., Bonivento, D., Chiarelli, L. R., and
Mattevi, A. (2009) ThermoFAD, a Thermofluor-adapted flavin ad hoc
detection system for protein folding and ligand binding. FEBS J. 276,
2833−2840.
(36) Kamerbeek, N. M., Olsthoorn, A. J., Fraaije, M. W., and Janssen,
D. B. (2003) Substrate specificity and enantioselectivity of 4-
hydroxyacetophenone mono-oxygenase. Appl. Environ. Microbiol. 69,
419−426.
(18) Macheroux, P. (1999) UV-Visible spectroscopy as a tool to
study flavoproteins. Methods Mol. Biol. 131, 1−7.
(37) Entsch, B., Ballou, D. P., and Massey, V. (1976) Flavin-oxygen
derivatives involved in hydroxylation by p-hydroxybenzoate hydrox-
ylase. J. Biol. Chem. 251, 2550−2563.
(19) van Berkel, W. J., Kamerbeek, N. M., and Fraaije, M. W. (2006)
Flavoprotein mono-oxygenases, a diverse class of oxidative biocatalysts.
J. Biotechnol. 124, 670−689.
(38) Torres Pazmino, D. E., Baas, J. B., Janssen, D. B., and Fraaije, M.
̃
(20) Beaty, N. B., and Ballou, D. P. (1981) The oxidative half-
reaction of liver microsomal FAD-containing mono-oxygenase. J. Biol.
Chem. 256, 4619−4625.
W. (2008) The kinetic mechanism of phenylacetone mono-oxygenase
from Thermobifida fusca. Biochemistry 47, 4082−4093.
(39) Siddens, L. K., Krueger, S. K., Henderson, M. C., and Williams,
D. E. (2014) Mammalian flavin-containing mono-oxygenase (FMO)
as a source of hydrogen peroxide. Biochem. Pharmacol. 89, 141−147.
(40) Geier, M., Bachler, T., Hanlon, S. P., Eggimann, F. K.,
(21) Beaty, N. B., and Ballou, D. P. (1981) The reductive half-
reaction of liver microsomal FAD-containing mono-oxygenase. J. Biol.
Chem. 256, 4611−4618.
(22) Beaty, N. B., and Ballou, D. P. (1981) Transient kinetic study of
liver microsomal FAD-containing mono-oxygenase. J. Biol. Chem. 255,
3817−3819.
Kittelmann, M., Weber, H., Lutz, S., Wirz, B., and Winkler, M. (2015)
̈
Human FMO2-based microbial whole-cell catalysts for drug
metabolite synthesis. Microb. Cell Fact. 14, 82.
(41) Hanlon, S. P., Camattari, A., Abad, S., Glieder, A., Kittelmann,
(23) Palfey, B. A.; Massey, V. Flavin-Dependent Enzymes.
Comprehensive Biological Catalysis; Academic Press: San Diego, CA,
1998; Chapter 29, Vol 3, pp 83−154.
M., Lutz, S., Wirz, B., and Winkler, M. (2012) Expression of
̈
recombinant human flavin mono-oxygenase and moclobemide-N-
(24) Alfieri, A., Malito, E., Orru, R., Fraaije, M. W., and Mattevi, A.
(2008) Revealing the moonlighting role of NADP in the structure of a
flavin-containing mono-oxygenase. Proc. Natl. Acad. Sci. U. S. A. 105,
6572−6577.
oxide synthesis on multi-mg scale. Chem. Commun. 48, 6001−6003.
(42) Kirchmair, J., Goller, A. H., Lang, D., Kunze, J., Testa, B.,
̈
Wilson, I. D., Glen, R. C., and Schneider, G. (2015) Predicting drug
metabolism: experiment and/or computation? Nat. Rev. Drug Discovery
14, 387−404.
(43) Fraaije, M. W., Kamerbeek, N. M., van Berkel, W. J. H., and
Janssen, D. B. (2002) Identification of a Baeyer-Villiger mono-
oxygenase sequence motif. FEBS Lett. 518, 43−47.
(44) Mishin, V., Gray, J. P., Heck, D. E., Laskin, D. L., and Laskin, J.
D. (2010) Application of the Amplex red/horseradish peroxidase assay
(25) Orru, R., Pazmino, D. E., Fraaije, M. W., and Mattevi, A. (2010)
̃
Joint functions of protein residues and NADP(H) in oxygen activation
by flavin-containing mono-oxygenase. J. Biol. Chem. 285, 35021−
35028.
(26) Hines, R. N., Cashman, J. R., Philpot, R. M., Williams, D. E., and
Ziegler, D. M. (1994) The mammalian flavin-containing mono-
I
ACS Chem. Biol. XXXX, XXX, XXX−XXX